Halozyme Therapeutics: 2Q Earnings Snapshot
SAN DIEGO (AP) _ Halozyme Therapeutics Inc. (HALO) on Tuesday reported a loss of $22.9 million in its second quarter.
The San Diego-based company said it had a loss of 16 cents per share.
The biopharmaceutical company posted revenue of $35.2 million in the period.
Halozyme Therapeutics shares have declined 13 percent since the beginning of the year. The stock has risen 34 percent in the last 12 months.